BAM
Byrne Asset Management’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $302K | Buy |
+2,720
| New | +$302K | 0.2% | 85 |
|
|
2025
Q1 | – | Sell |
-3,230
| Closed | -$298K | – | 83 |
|
|
2024
Q4 | $298K | Sell |
3,230
-290
| -8% | -$26.8K | 0.21% | 86 |
|
|
2024
Q3 | $295K | Buy |
+3,520
| New | +$295K | 0.2% | 92 |
|
|
2024
Q2 | – | Sell |
-12,205
| Closed | -$894K | – | 98 |
|
|
2024
Q1 | $894K | Buy |
+12,205
| New | +$894K | 0.62% | 53 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 42 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 42 |
|
|
2023
Q2 | – | Sell |
-13,027
| Closed | -$1.08M | – | 44 |
|
|
2023
Q1 | $1.08M | Sell |
13,027
-605
| -4% | -$50.2K | 0.77% | 36 |
|
|
2022
Q4 | $1.17M | Sell |
13,632
-1,540
| -10% | -$132K | 0.85% | 30 |
|
|
2022
Q3 | $936K | Sell |
15,172
-205
| -1% | -$12.6K | 0.72% | 40 |
|
|
2022
Q2 | $950K | Buy |
15,377
+250
| +2% | +$15.4K | 0.7% | 46 |
|
|
2022
Q1 | $899K | Buy |
15,127
+2,775
| +22% | +$165K | 0.56% | 58 |
|
|
2021
Q4 | $897K | Buy |
+12,352
| New | +$897K | 0.58% | 52 |
|